$MLRT
Metalert, Inc. Stock $mlrt

$mlrt Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032538 Filed on November 15, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q4
Revenue	$34.04K	$67.65K	$47.76K
YoY Change	-28.73%	-55.36%	-62.74%
Cost Of Revenue	$26.59K	$26.35K	$70.58K
YoY Change	-62.33%	-61.33%	-44.94%
Gross Profit	$7.450K	$41.31K	-$22.82K
YoY Change	-132.65%	-50.49%
Gross Profit Margin	21.89%	61.05%	-47.78%
Selling, General & Admin	$691.0K	$71.76K	$268.0K
YoY Change	157.85%	-4.42%	-0.44%
% of Gross Profit	9274.9%	173.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.34K		$8.340K
YoY Change	299.76%		34.73%
% of Gross Profit	447.52%
Operating Expenses	$699.3K	$281.5K	$276.3K
YoY Change	153.08%	0.85%	2.66%
Operating Profit	-$691.9K	-$240.2K	-$299.1K
YoY Change	131.28%	22.73%	11.13%
Interest Expense	-$55.17K		-$26.20K
YoY Change	110.57%		-34.14%
% of Operating Profit
Other Income/Expense, Net	-$100.9K	-$62.28K	-$183.1K
YoY Change	-44.92%	279.04%	-1064.24%
Pretax Income	-$780.0K		-$442.4K
YoY Change	76.31%		10.14%
Income Tax
% Of Pretax Income
Net Earnings	-$780.0K	-$302.5K	-$442.4K
YoY Change	76.31%	42.58%	10.14%
Net Earnings / Revenue	-2291.48%	-447.08%	-926.32%
Basic Earnings Per Share		-$0.06
Diluted Earnings Per Share	-$0.05	-$0.06	-$2.000K
COMMON SHARES
Basic Shares Outstanding	15.57M shares	247.1M shares	225.0M shares
Diluted Shares Outstanding		5.066M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.220K		$140.8K
YoY Change	-93.45%		73.67%
Cash & Equivalents	$8.534K	$24.00K	$138.3K
Short-Term Investments	$680.00		$2.470K
Other Short-Term Assets	$8.045K	$17.83K	$55.02K
YoY Change	-85.38%	-87.83%	0.77%
Inventory	$70.11K	$91.00K	$98.26K
Prepaid Expenses
Receivables	$13.96K		$13.74K
Other Receivables	$0.00		$0.00
Total Short-Term Assets	$101.3K	$157.2K	$307.8K
YoY Change	-67.08%	-73.78%	6.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$59.12K	$67.46K	$92.46K
YoY Change	-36.06%	3.34%	1073.66%
Goodwill
YoY Change
Intangibles	$3.308K	$3.308K	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$62.43K	$70.76K	$92.46K
YoY Change	-32.48%	8.41%	1073.66%
TOTAL ASSETS
Total Short-Term Assets	$101.3K	$157.2K	$307.8K
Total Long-Term Assets	$62.43K	$70.76K	$92.46K
Total Assets	$163.8K	$228.0K	$400.3K
YoY Change	-59.09%	-65.71%	34.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$137.3K	$127.2K	$182.6K
YoY Change	-24.8%	-7.05%	0.0%
Accrued Expenses	$388.4K	$334.1K	$327.3K
YoY Change	18.67%	16.44%	0.0%
Deferred Revenue	$12.85K	$15.98K	$37.35K
YoY Change	-65.6%	-48.43%	0.0%
Short-Term Debt	$2.209M
YoY Change
Long-Term Debt Due	$89.55K		$81.95K
YoY Change	9.27%		277.3%
Total Short-Term Liabilities	$3.335M	$3.179M	$3.137M
YoY Change	6.3%	5.37%	-1.49%
LONG-TERM LIABILITIES
Long-Term Debt	$142.1K		$142.9K
YoY Change	-0.57%		-34.4%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$142.1K		$142.9K
YoY Change	-0.57%		-34.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.335M	$3.179M	$3.137M
Total Long-Term Liabilities	$142.1K		$142.9K
Total Liabilities	$3.477M	$3.322M	$3.280M
YoY Change	6.0%	2.71%	-3.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.56M	-$26.78M	-$26.05M
YoY Change	5.77%	4.55%	7.76%
Common Stock	$1.718K	$1.556K	$22.45K
YoY Change	-92.35%	-92.76%	62.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.313M	-$3.094M	-$2.880M
YoY Change
Total Liabilities & Shareholders Equity	$163.8K	$228.0K	$400.3K
YoY Change	-59.09%	-65.71%	34.24%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q4
OPERATING ACTIVITIES
Net Income	-$780.0K	-$302.5K	-$442.4K
YoY Change	76.31%	42.58%	10.14%
Depreciation, Depletion And Amortization	$33.34K		$8.340K
YoY Change	299.76%		34.73%
Cash From Operating Activities	-$507.0K		-$119.7K
YoY Change	323.69%		-14.86%
INVESTING ACTIVITIES
Capital Expenditures			-$35.52K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$3.310K		$0.00
YoY Change
Cash From Investing Activities	-$3.310K		-$35.52K
YoY Change	-90.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	380.5K		0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-507.0K		-119.7K
Cash From Investing Activities	-3.310K		-35.52K
Cash From Financing Activities	380.5K		0.000
Net Change In Cash	-129.8K		-155.2K
YoY Change	-16.34%		3.1%
FREE CASH FLOW
Cash From Operating Activities	-$507.0K		-$119.7K
Capital Expenditures			-$35.52K
Free Cash Flow			-$84.13K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001375793
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022Q3	MLRT	Grant From Care Loans GrantFromCareLoans		usd
CY2021Q3	MLRT	Grant From Care Loans GrantFromCareLoans		usd
	MLRT	Grant From Care Loans GrantFromCareLoans		usd
CY2022Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2021Q3	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2022Q3	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2021Q3	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2022Q3	MLRT	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne		usd
CY2021Q3	MLRT	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne		usd
	MLRT	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne		usd
	MLRT	Stock Returned During Period Value Preferred Stock To Treasury StockReturnedDuringPeriodValuePreferredStockToTreasury		usd
	MLRT	Issuance Of Common Stock For Conversion Of Warrants One IssuanceOfCommonStockForConversionOfWarrantsOne		usd
	MLRT	Issuance Of Common Stock Value For Conversion Of Preferred Shares IssuanceOfCommonStockValueForConversionOfPreferredShares		usd
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	MLRT	Grant From Care Loans GrantFromCareLoans		usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
	MLRT	Interest And Financing Cost On Lt Convertible Debt InterestAndFinancingCostOnLtConvertibleDebt		usd
	MLRT	Issuance Of Common Stock For Financings IssuanceOfCommonStockForFinancings		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	MLRT	Deemed Dividend DeemedDividend		usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1		usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross		usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization		usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2021Q4	us-gaap	Other Borrowings OtherBorrowings		usd
CY2022Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2022Q3	MLRT	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount		usd
	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53046
	dei	Entity Registrant Name EntityRegistrantName	METALERT INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0493446
	dei	Entity Address Address Line1 EntityAddressAddressLine1	117 W. 9th Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1214
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90015
	dei	City Area Code CityAreaCode	213
	dei	Local Phone Number LocalPhoneNumber	489-3019
	dei	Entity Information Former Legal Or Registered Name EntityInformationFormerLegalOrRegisteredName	GTX Corp
	dei	Security12b Title Security12bTitle	None
	dei	Trading Symbol TradingSymbol	GTXO
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15568504	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23998	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138342	usd
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	23328	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13735	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	90997	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1096	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	17827	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	55016	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	157246	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	307816	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67456	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2022Q3	us-gaap	Assets Assets	228010	usd
CY2021Q4	us-gaap	Assets Assets	400277	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	127220	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	182610	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	334106	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327293	usd
CY2022Q3	MLRT	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	579245	usd
CY2021Q4	MLRT	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	839810	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15975	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37350	usd
CY2022Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	17000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	21715	usd
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	6625	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2022Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	843000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2022Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1104585	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	976545	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	150875	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3178631	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3136981	usd
CY2022Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	143375	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142917	usd
CY2022Q3	us-gaap	Liabilities Liabilities	3322006	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3279898	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15565927	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15565927	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3453885	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3453885	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1556	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	345	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23680890	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23173403	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26776456	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26053384	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3093996	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	228010	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400277	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	67653	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	151554	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300570	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541678	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26349	usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68130	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	163173	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	263611	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	41305	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	83424	usd
	us-gaap	Gross Profit GrossProfit	137397	usd
	us-gaap	Gross Profit GrossProfit	278067	usd
CY2022Q3	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	127829	usd
CY2021Q3	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	138137	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	382916	usd
	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	358099	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	81893	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	65902	usd
	us-gaap	Professional Fees ProfessionalFees	257232	usd
	us-gaap	Professional Fees ProfessionalFees	263863	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3494	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5083	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19092	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	74821	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	68269	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70001	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	156670	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	159702	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	281485	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	279123	usd
	us-gaap	Operating Expenses OperatingExpenses	815911	usd
	us-gaap	Operating Expenses OperatingExpenses	883484	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-240180	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-195699	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-678514	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-605418	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66036	usd
CY2022Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-94	usd
CY2021Q3	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1101	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1369	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-419	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	16526	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	29089	usd
	MLRT	Grant From Care Loans GrantFromCareLoans	67870	usd
	MLRT	Edd Recovery Due To Covid EddRecoveryDueToCovid	34191	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	30705	usd
CY2022Q3	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-45663	usd
CY2021Q3	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-15331	usd
	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-116161	usd
	MLRT	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-55469	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-62284	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16432	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-44558	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	60349	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-152628	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-302463	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-212131	usd
	us-gaap	Net Income Loss NetIncomeLoss	-723072	usd
	us-gaap	Net Income Loss NetIncomeLoss	-758046	usd
	MLRT	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne	675000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-302463	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-212131	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-723072	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1433046	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5066220	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3306193	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4161828	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2974597	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3052303	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	57109	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	114062	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30492	usd
CY2022Q3	MLRT	Issuance Of Common Stock For Conversion Of Warrants One IssuanceOfCommonStockForConversionOfWarrantsOne	985	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-302463	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3093996	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-2360358	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2960	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2569529	usd
	us-gaap	Net Income Loss NetIncomeLoss	-723072	usd
	us-gaap	Net Income Loss NetIncomeLoss	-758046	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25005	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7103	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-212131	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-2569529	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	129286	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	180000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	114062	usd
	MLRT	Issuance Of Common Stock For Conversion Of Warrants One IssuanceOfCommonStockForConversionOfWarrantsOne	25000	usd
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	60349	usd
	us-gaap	Net Income Loss NetIncomeLoss	-723072	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3093996	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3104097	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	241110	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14075	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	194373	usd
	MLRT	Issuance Of Preferred Stock For Financing IssuanceOfPreferredStockForFinancing	675000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3275	usd
	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	131736	usd
	MLRT	Adjustment To Additional Paid In Capital Imputed Interest Related Parties AdjustmentToAdditionalPaidInCapitalImputedInterestRelatedParties	30705	usd
	MLRT	Inpixon Loan Reduction Correction InpixonLoanReductionCorrection	2340	usd
	us-gaap	Net Income Loss NetIncomeLoss	-758046	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	34675	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1369	usd
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-419	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	129286	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	255185	usd
	MLRT	Grant From Care Loans GrantFromCareLoans	67870	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	29089	usd
	MLRT	Interest And Financing Cost On Lt Convertible Debt InterestAndFinancingCostOnLtConvertibleDebt	116641	usd
	MLRT	Issuance Of Common Stock For Financings IssuanceOfCommonStockForFinancings	43413	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66036	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2340	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	30705	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9592	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	41963	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-7261	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4710	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-37189	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	91864	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-33563	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-30990	usd
	MLRT	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	82698	usd
	MLRT	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	106621	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21275	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6370	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-426835	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-378026	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3308	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64500	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1258	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3308	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63242	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	69180	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	675000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	25000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	180000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	145000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	59180	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	44201	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	17123	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	315799	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	657877	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-114345	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	216609	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76912	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23998	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	293521	usd
	us-gaap	Interest Paid Net InterestPaidNet	623	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	114062	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	194373	usd
	MLRT	Deemed Dividend DeemedDividend	675000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2841	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-3093996	usd
CY2022Q3	MLRT	Working Capital WorkingCapital	-3021385	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300570	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541678	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300570	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	541678	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	90997	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	32162	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	71936	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	58835	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25322	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	38920	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase.
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zc6wcRf53hA7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_867_zQHwH8f9F8Pg">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zAQM3VIBEtsb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zkTNKZ3ijGh8">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2022, the Company had five customers representing approximately<span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbZ8UUVXRsBh" title="Concentration risk, percentage"> 28</span>%, <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zwyRFGCY0Aza" title="Concentration risk, percentage">23</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zberh7RcCbp7" title="Concentration risk, percentage">16</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_zvCXGRAn6Vnd" title="Concentration risk, percentage">6</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFiveMember_zgprN0O6IQf7" title="Concentration risk, percentage">6</span>% of sales, respectively (<span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zcLnNUW6AaY6" title="Concentration risk, percentage">34</span>% in receivables represents sales made through our online stores and consists of approximately 2,000 different customers), and five customers representing approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAUL1FOIEC3h" title="Concentration risk, percentage">25</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zSF58p8anRA5" title="Concentration risk, percentage">18</span>%, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zQin9EVnIjo7" title="Concentration risk, percentage">18</span>, <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zZnnTSyDdwr" title="Concentration risk, percentage">12</span>%% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFiveMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z2h3aU6pEmm7" title="Concentration risk, percentage">8</span>% of total accounts receivable, respectively (excluding related party payables).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2021, the Company had three customers representing approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zd68FqOL4FG5">76</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zNwZfvv9Pcd2">8</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zJmW8ONyBjLg">4</span>% of sales, respectively, and three customers representing approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z35783Z5E03j">31</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zoeUeIAGavMe">13</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z1I3C2bn56K2">8</span>% of total accounts receivable, respectively (of the <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zHCi7iqcnYd5">76</span>% of sales, this represents all sales made through our online store and consists of approximately 2,000+ different customers).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1096	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q3	MLRT	Convertible Debt Liability ConvertibleDebtLiability	0	usd
CY2021Q4	MLRT	Convertible Debt Liability ConvertibleDebtLiability	0	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	174889151	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	121188985	shares
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
	MLRT	Investment Owned Description InvestmentOwnedDescription	The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations.
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8500	shares
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	446578	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	421573	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	67456	usd
	us-gaap	Depreciation Depreciation	25005	usd
	us-gaap	Depreciation Depreciation	7103	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3308	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3308	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	150875	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2022Q3	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2022Q3	us-gaap	Other Borrowings OtherBorrowings	10000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	167875	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	47640	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	848000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	843000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	MLRT	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2022Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	6625	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7083	usd
CY2022Q3	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	143375	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142917	usd
CY2022Q3	MLRT	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	150000	usd
CY2021Q4	MLRT	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	217870	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	367901	usd
	MLRT	Due To Related Parties Amount Converted Into Notes DueToRelatedPartiesAmountConvertedIntoNotes	367901	usd
CY2022Q3	us-gaap	Convertible Debt ConvertibleDebt	108602	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10860200	shares
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021	MLRT	Deemed Dividend DeemedDividend	675000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	757692	shares
	MLRT	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.16
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	153846	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	603846	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	153846	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.016
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q3	MLRT	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd

Files In Submission

Name	View Source	Status
0001493152-22-032538-index-headers.html	Edgar Link	pending
0001493152-22-032538-index.html	Edgar Link	pending
0001493152-22-032538.txt	Edgar Link	pending
0001493152-22-032538-xbrl.zip	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-1_001.jpg	Edgar Link	pending
ex3-1_002.jpg	Edgar Link	pending
ex3-1_003.jpg	Edgar Link	pending
ex3-1_004.jpg	Edgar Link	pending
ex3-1_005.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlrt-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
mlrt-20220930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mlrt-20220930_def.xml	Edgar Link	unprocessable
mlrt-20220930_lab.xml	Edgar Link	unprocessable
mlrt-20220930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLRT
Metalert, Inc. Stock $mlrt

2022 Q4 Form 10-Q Financial Statement

#000149315222032538 Filed on November 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT Metalert, Inc. Stock $mlrt

2022 Q4 Form 10-Q Financial Statement

#000149315222032538 Filed on November 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT
Metalert, Inc. Stock $mlrt